➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:


Last Updated: June 5, 2020

DrugPatentWatch Database Preview

Litigation Details for Novo Nordisk Inc. v. Actavis Pharma Manufacturing Pvt. Ltd. LLC (S.D.N.Y. 2009)

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Novo Nordisk Inc. v. Actavis Pharma Manufacturing Pvt. Ltd. LLC (S.D.N.Y. 2009)

Docket   Start Trial Date Filed 2009-10-23
Court District Court, S.D. New York Date Terminated 2010-11-08
Cause 35:145 Civil Action to Obtain Patent Assigned To Paul G. Gardephe
Jury Demand None Referred To
Patents 6,677,358
Attorneys Aric Hugo Wu; Jo-Anne M. Kokoski; Jonathan A. Harris; Jonathan H Harris; Josh Andrew Krevitt; Lauren Stacey Albert; Michael A. Sitzman; Nicholas Emrys Owen Gaglio; Stacie L. Ropka; Wayne M. Barsky
Firms Axinn, Veltrop & Harkrider LLP; Axinn, Veltrop & Harkrider LLP (Hartford, Conn.); Cantor Colburn LLP; Gibson, Dunn & Crutcher, LLP (CA); Gibson, Dunn & Crutcher, LLP (LA); Gibson, Dunn & Crutcher, LLP (NY)
Link to Docket External link to docket
Small Molecule Drugs cited in Novo Nordisk Inc. v. Actavis Pharma Manufacturing Pvt. Ltd. LLC
The small molecule drugs covered by the patent cited in this case are   Start Trial and   Start Trial .

Details for Novo Nordisk Inc. v. Actavis Pharma Manufacturing Pvt. Ltd. LLC (S.D.N.Y. 2009)

Date Filed Document No. Description Snippet Link To Document
2009-10-23 1 Complaint infringement of United States Patent No. 6,677,358 pursuant to the patent laws of the United States, 35…2004, United States Patent No. 6,677,358, entitled “NIDDM Regimen,” (the “’358 patent”) was duly and legally…Page 6 018 Count I: Infringement of U.S. Patent No. 6,677,358 24. Novo Nordisk hereby realleges and incorporates…to be, the sole owner of the ’358 patent. A copy of the ’358 patent is attached hereto and incorporated… infringement of the ’358 patent, prior to the expiration of the ’358 patent, including any extensions External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.